Evaluating consistency in the interpretation of NTP rodent cancer bioassays: An examination of mouse lung tumor effects in the 4-MEI study

- 4-MEI increased lung tumor incidence in mice in an NTP cancer bioassay.
- We demonstrated that this response was consistent with previous “some evidence of carcinogenicity” NTP calls.
- The NTP called the effect “clear evidence of carcinogenic activity”.
- The NTP “category of evidence” call is important to the regulatory community, so maintaining consistency is important.
- Suggestions are given as to how the NTP could enhance consistency in the interpretation of future rodent cancer bioassays.

The potential carcinogenicity of 4-methylimidazole (4-MEI) was evaluated in a National Toxicology Program (NTP) rodent cancer bioassay in Fischer 344 rats and B6C3F1 mice (NTP, 2007; Chan et al., 2008). The NTP concluded that there was “clear evidence of carcinogenic activity” in male and female mice, based on an increased incidence of lung tumors. The “category of evidence” that the NTP assigns to a rodent cancer bioassay outcome can have significant regulatory implications. This is especially important for 4-MEI, which forms in caramel colorings and other foods during cooking, with potential widespread human exposure in a broad spectrum of food and beverage products. A detailed analysis of all NTP mouse-lung-tumor-only carcinogens reveals that the proper call for lung tumors in the 4-MEI study should have been “some evidence” rather than “clear evidence” of carcinogenic activity for both male and female mice in order to be consistent with the NTP's interpretation of other mouse lung carcinogens showing a similar strength of response. Suggestions are given as to measures the NTP should consider in the preparation of some or all future Technical Reports in order to enhance consistency of interpretation of experimental results.